1Pruss TP,Stoiβnig H,Radhofer Welte S,et al.Overview of the pharmacological properties, pharmacokinetics and animal safety assessment of lornoxicam[].Postgraduate Medical Journal.1990
2Olkkola KT,Brunetto AV,Mattila MJ.Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents[].Clinical Pharmacokinetics.1994
3Nuutinen LS,Laitinen JO,Salomaki TE.A risk-benefit appraisal of injectable NSAIDs in the management of postoper-ative pain[].Drug Safety.1993
4Kullich W,Klein G.Influence of the nonsteroidal anti-inflammatory drug lornoxicam on the secretion of the endogenous opiate peptides dynorphin andβ-endorphin[].Aktuelle Rheumatologie.1992
5Detlef ER,Morten A,Diet mars.A comparison of patient-con-trolled analgesia withlornoxicam versus morphine in patients un-dergoing lumbar disk surgery[].Anesthesia and Analgesia.1998
6Norholt SE,Sindet-Pedersen S,Larsen U,et al.Pain control after dental surgery: a double blind, randomised trial of lornoxicam versus morphine[].Pain.1996
7Berg J,Christoph T,Widerna M,et al.Isoenzyme-specific cyclooxygenase inhibitors:a whole cell assay system using the human erythroleukemic cell line HEL and the human monocytic cell line Mono Mac6[].Journal of Pharmacological and Toxicological Methods.1997
2Maletzkii C,Emmrich J.Inflammation and immunity in the tumor environment[J].Dig Dis,2010,28(4-5):574-578.
3Diakos CI,Charles KA,Mcmillan DC,et al.Cancer-related inflammation and treatment effectiveness[J].Lancet Oncol,2014,15(11):e493-e503.
4Richards P,Riff D,Kelen R,et al.A phase 3,randomized,double-blind comparison of analgesic efficacy and tolerability of Q8003 vs oxycodone or morphine for moderate-to-severe postoperative pain following bunionectomy surgery[J].Pain Med,2013,14(8):1230-1238.
5Melson T,Boyer DL,Minkowitz HS,et al.Sufentanil sublingual tablet system vs.intravenous patient-controlled analgesia with morphine for postoperative pain control:a randomized,active-comparator trial[J].Pain Pract,2014,14(8):679-688.
6Liao SL,Chen WY,Raung SL,et al.Neuroprotection of naloxone against ischemic injury in rats:role of mu receptor antagonism[J].Neurosci Lett,2003,345(3):169-172.
7Liu R,Huang XP,Yeliseev A,et al.Novel molecular targets of dezocine and their clinical implications[J].Anesthesiology,2014,120(3):714-723.
